Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Buprenorphine vs. Opioid Dose Escalation in Chronic Pain
NCT01875848Phase 4Terminated
- Sponsor
- VA Office of Research & Development
- Start
- Dec 2013
- Primary completion
- Jun 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of buprenorphine + naloxone in chronic pain, sponsored by VA Office of Research & Development. Started Dec 2013; status: terminated.
02
Drugs
buprenorphine + naloxone
03
Conditions
chronic pain
Beyond the preview
Go deeper on NCT01875848.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01875848.